Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
arginine hydrochloride, Quantity: 250 mg; d-alpha-tocopheryl acid succinate, Quantity: 15 mg; Rhodiola rosea, Quantity: 50 mg (Equivalent: Rhodiola rosea, Qty 1 g; Equivalent: rosavin (of Rhodiola rosea), Qty 0.5 mg; Equivalent: Salidroside (of Rhodiola rosea), Qty 0.5 mg); nicotinamide, Quantity: 13.75 mg; Epimedium sagittatum, Quantity: 37.5 mg (Equivalent: Epimedium sagittatum, Qty 750 mg); Tribulus terrestris, Quantity: 37.5 mg (Equivalent: Tribulus terrestris, Qty 1.875 g); Dulacia inopiflora, Quantity: 50 mg (Equivalent: Dulacia inopiflora, Qty 500 mg); Lepidium meyenii, Quantity: 50 mg (Equivalent: Lepidium meyenii, Qty 500 mg); Vitex agnus-castus, Quantity: 40 mg (Equivalent: Vitex agnus-castus, Qty 400 mg); Avena sativa, Quantity: 36 mg (Equivalent: Avena sativa, Qty 360 mg); Hypericum perforatum, Quantity: 35 mg (Equivalent: Hypericum perforatum, Qty 210 mg); Piper nigrum, Quantity: 0.3 mg (Equivalent: Piper nigrum, Qty 15 mg)
Vitex Pharmaceuticals Pty Ltd
Capsule, hard
Excipient Ingredients: colloidal anhydrous silica; magnesium stearate; hypromellose; purified water; carrageenan; potassium acetate
Oral
Visual Identification: Brown powder in a clear vegetable capsule; Container Type: Carton
Listed (Export Only)
2022-05-26